$QURE

uniQure N.V.

Nasdaq · Healthcare · Pharmaceutical Preparations · Amsterdam

QURE chart

What traders are saying about $QURE

Latest posts

uniQure N.V. news

uniQure N.V. key financials

USD2025202420232022
Revenue––––
Net income-$199.0M-$239.6M-$308.5M-$126.8M
Diluted EPS$-3.46$-4.92$-6.47$-2.71
Total assets (year end)$824.9M$556.5M$831.7M$705.0M
Cash and equivalents (year end)$80.2M$158.9M$241.4M$228.0M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About uniQure N.V.

Ticker
QURE (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Amsterdam
Fiscal year end
December 31
SEC CIK
1590560
Former names
uniQure B.V.

Frequently asked questions

What exchange is uniQure N.V. listed on?

uniQure N.V. trades on the Nasdaq under the ticker symbol QURE.

What industry is uniQure N.V. in?

uniQure N.V. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is uniQure N.V. headquartered?

uniQure N.V.'s business address on file with the SEC is in Amsterdam.

When does uniQure N.V.'s fiscal year end?

uniQure N.V.'s fiscal year ends on December 31.

How much revenue did uniQure N.V. report?

uniQure N.V. reported $13.1M in revenue for calendar year 2017, according to its SEC filings.